pharma is the sole category represented across all 1 tracked stories. For-profit methadone clinic chains is most often covered alongside Buprenorphine, which appears in 1 of these 1 story. Each carries 4 original sources on average. We currently track 1 Biotech story that mention For-profit methadone clinic chains, all published on September 12, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about For-profit methadone clinic chains
pharma is the sole category represented across all 1 tracked stories. For-profit methadone clinic chains is most often covered alongside Buprenorphine, which appears in 1 of these 1 story. Each carries 4 original sources on average. We currently track 1 Biotech story that mention For-profit methadone clinic chains, all published on September 12, 2026.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering For-profit methadone clinic chains. Shared-story counts are live from our verified record — not editorial picks.
For drug developers and pharma strategists, methadone is a market anomaly: a decades-old generic full agonist that many patients prefer over buprenorphine because it binds more completely to opioid receptors, yet its clinic-only distribution model has frozen product innovation and competition. The investigation underscores how a molecule's regulatory pathway, not its pharmacology, can define its market for half a century.
For-profit methadone clinic chains is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.
